Several ruthenium(II) complexes with new tridentate polypyridine ligands have been prepared, and their photophysical properties have been studied. The new tridentate ligands are tpy-modified systems (tpy = 2,2':6',2' '-terpyridine) in which aromatic substituents designed to be coplanar with the tpy moiety are introduced, with the aim of enhancing delocalization in the acceptor ligand of the potentially luminescent metal-to-ligand charge-transfer (MLCT) state and increasing the MLCT-MC energy gap (MC = metal-centered excited state). Indeed, the Ru(II) complexes obtained with this new family of tridentate ligands exhibit long-lived luminescence at room temperature (up to 200 ns). The enhanced luminescence properties of these complexes support this design strategy and are superior to those of the model Ru(tpy)22+ compound and compare favorably with those of the best Ru(II) complexes with tridentate ligands reported so far.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: